JWH-398
JWH-398[edit]
JWH-398 is a synthetic cannabinoid that acts as a potent agonist at the cannabinoid receptors. It is part of the naphthoylindole family of compounds and is used in scientific research to study the endocannabinoid system.
Chemical Properties[edit]
JWH-398 is chemically classified as a naphthoylindole, which is a type of synthetic cannabinoid. Its chemical structure includes a naphthalene ring linked to an indole group. The full chemical name is 1-Pentyl-3-(4-chloro-1-naphthoyl)indole.
Pharmacology[edit]
JWH-398 acts as a full agonist at both the CB1 and CB2 cannabinoid receptors. These receptors are part of the endocannabinoid system, which plays a role in regulating various physiological processes such as pain, appetite, and mood.
CB1 Receptor[edit]
The CB1 receptor is primarily found in the central nervous system, including the brain. Activation of this receptor by JWH-398 can lead to psychoactive effects similar to those produced by tetrahydrocannabinol (THC), the active component of cannabis.
CB2 Receptor[edit]
The CB2 receptor is mainly located in the peripheral nervous system and is associated with the immune system. JWH-398's action on the CB2 receptor is thought to modulate inflammation and immune response.
Legal Status[edit]
Due to its potential for abuse and lack of medical use, JWH-398 has been classified as a controlled substance in many countries. It is often included in the list of substances banned under synthetic cannabinoid regulations.
Research Applications[edit]
JWH-398 is used in research to better understand the endocannabinoid system and the effects of synthetic cannabinoids. Studies often focus on its binding affinity to cannabinoid receptors and its potential therapeutic applications.
Health Effects[edit]
The use of JWH-398 can lead to various health effects, including tachycardia, hypertension, and hallucinations. Long-term effects are not well-studied, but concerns exist regarding its impact on mental health and potential for addiction.
Related Pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa
Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends ✔ Tele visits available with certain limitations Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
